The effects of neuropeptide Y (NPY) and cal citonin gene-related peptide (CORP) on local cerebral blood flow (LCBF) were studied in vivo in rat striatum. Administration of 1 and 5 nmol NPY as a bolus into the internal carotid artery caused a dose-dependent decrease in the ipsilateral striatal LCBF. This decrease developed slowly and persisted for at least 2 h, without affecting mean blood pressure. In contrast, CORP, at a concentra tion of 10 pmol, increased striatal LCBF by about 30%,
The importance of neural activity in the regula tion of CBF has long been a subject of controversy.
Apart from the modulation of cerebrovascular re sistance, a number of cerebral circulatory re sponses are not sufficiently explained by the adren ergic and cholinergic mechanisms of the autonomic nervous system. However, recent advances in his tochemical techniques, particularly in immunohis tochemistry, have revealed the existence of several pep tides within the nerve fibers that innervate the cerebral blood vessels. The vasoactive effects of these peptides have been demonstrated in studies of their actions on vascular smooth muscle in vitro and in situ and on CBF in vivo. The data obtained so far suggest that neuropeptides released from perivas cular nerves act as major transmitters in the neural regulation of CBF. Among the neuropeptides that have been identified in perivascular nerves, neuro peptide Y (NPY) is known to function as a vaso constrictor (Edvinsson et aI., 1984; Suzuki et aI., 1988) and vasoactive intestinal peptide (Lee et aI., 1984; Suzuki et aI., 1984) , peptide histidine and iso-and the duration of the increase was about 1 h. However, at higher doses of CORP no increase in LCBF was ob served. These results suggest that NPY and CORP re leased from nerve fibers innervating blood vessels can function as long-acting modulators of CBF. Key Words: Neuropeptide Y -Calcitonin gene-related peptide Local cerebral blood flow-Vasoconstriction-Vaso dilatation.
leucine (Suzuki et aI., 1984) , substance P (Mosko witz et aI., 1987), and calcitonin gene-related pep tide (CGRP) (Hanko et aI., 1985; McCulloch et aI., 1986) as vasodilators.
This study was designed to evaluate the effects of NPY and CGRP on local CBF (LCBF) in rat stria tum.
METHODS
Male Sprague-Dawley rats weighing 250-300 g were anesthetized with intraperitoneal injection of pentobar bital (50 mg/kg) and subsequent subcutaneous injection of pentobarbital as required. After the administration of at ropine (0.1 mg/kg i. p.) and pancuronium bromide (2 mg/ kg i.p.), the rats were artificially ventilated via a trache ostomy tube with room air delivered by a small animal respirator (Shinano, model SN 480-7). A polyethylene catheter was inserted into the left femoral artery for mon itoring of mean arterial blood pressure (MABP) and arte rial blood sampling for gas analysis. In most cases, two arterial samples were taken from each rat for blood gas analysis, one shortly before peptide injection and another after the final measurement of LCBF. A second catheter was inserted via the left external carotid artery into the common carotid artery. The external carotid artery was ligated for selective infusion of peptides into the left in ternal carotid artery. Vehicle (0.2 ml saline solution) or peptide (in 0.2 ml vehicle) was given by microinjection into the internal carotid artery over a period of 10 s. Body temperature was measured rectally and maintained within 36S to 37SC by a heating lamp. LCBF was measured by the hydrogen clearance method, with hydrogen gas generated by the electrolysis of water (Koshu et aI., 1982; Okada et aI., 1988) by means of an acutely implanted needle electrode (diameter 400 11m, BE-ND, Biomedical Science Co., Tokyo). A burr hole was drilled into the skull with the aid of a surgical microscope, and the needle electrode was placed stereo tactically into the lateral part of the striatum 1 mm ante rior, 4 mm lateral, and 4 mm ventral to the bregma. A reference electrode was placed subcutaneously in the scalp. Mter generation of the hydrogen gas, the polaro graphic current within the brain was measured, and the hydrogen clearance curve was obtained (RBF-2, Biomed ical Science Co., Tokyo). LCBF values were calculated by a computerized system (BDA-I-2, Biomedical Science Co., Tokyo). Each absolute value was corrected by de ducting the residual value after cardiac arrest. The LCBF values obtained after administration of vehicle or peptide were expressed as percentages of baseline values (the latter, represented as 100%, being the mean of two LCBF measurements taken before administration of vehicle or peptide). Measurements of LCBF were continued at lO IS min intervals for 2 h. All responses are expressed as the mean ± SEM. The results obtained after administration of vehicle or peptide were compared by means of analysis of variance and Duncan's multiple comparison. A value of p < 0.05 was considered significant. Fig. 1 . The 1nmol dose of NPY (n = 5) reduced striatal LCBF (39.7 ± 2.9 mllmin/lOO g) by about 20% from base line (49.4 ± 1.3 mllmin/IOO g) at 40 min, after which LCBF recovered. The higher dose of 5 nmol (n = 10) reduced striatal LCBF (24.5 ± 4.9 mllmin/lOO g) by about 47% from the initial value (46.4 ± 2.0 mIl min/lOO g), and the reduction lasted at least 2 h.
RESULTS

Injection
A lO-pmol dose of CGRP administered into the carotid artery (n = 5) produced a significant in crease in LCBF in the striatum (Fig. 2) . The peak value (74.7 ± 4.9 mllmin/lOO g), which was about 130% of baseline (57.5 ± 1.9 ml/min/lOO g), was observed after 40 min and subsequently declined. However, a lOO-pmol dose of CGRP (n = 4) re sulted in no significant alteration relative to baseline values, and a CGRP dose of 1 nmol actually caused a decrease in LCBF as well as systemic hypoten sion (data not shown).
The administration of NPY or CGRP did not sig nificantly alter mean blood pressure. Measurements ofPao2, Paco2, and pH before and after administra tion of NPY or CGRP also remained unaffected by the test agents ( Table 1) . blood vessels, NPY is the most potent known va soconstrictor and coexists with norepinephrine (N A) within sympathetic nerves (Edvinsson et aI., 1984) . CGRP, a potent vasodilator, functions in concert with substance P and possibly with other tachykinins in the cerebral branches of the trigem inal nerve (Moskowitz et aI., 1987) . We found, in a previous study (Suzuki et aI., 1988) , that NPY con stricts canine isolated middle cerebral and basilar arteries and that bolus intra-arterial administration of NPY reduces canine vertebral blood flow. Both of these effects developed slowly and persisted, which is consistent with our present observations in rat striatal LCBF. Allen et ai. (1984) , who also used the hydrogen clearance method, described a large magnitude and long duration of NPY -induced re duction in rat cerebral cortical blood flow after uni lateral carotid injection. However, another study (Tuor et aI., 1985) involving e 4 C]iodoantipyrine quantitative autoradiography in rats failed clearly to demonstrate a focal reduction in CBF 15 min after injection of NPY under similar conditions. As re ductions of CBF became significant 30 min after the administration of NPY according to our present data; these observations are not contradictory. It seems likely from the present data and our previous data in dogs (Suzuki et aI., 1988) known to cause systemic hypotension accompanied by a potent positive chronotrophic effect on atrium (Saito et aI., 1986) . Thus, the amount of CGRP nec essary to produce an increase in LCBF appears to be approximately 10 pmol or less, and the duration of its effect is relatively long.
Intra-arterial administration of NPY and CGRP may seem unusual under physiological circum stances, since these peptides generally modulate vascular smooth muscle tone after their release from nerve fibers. However, the evidence indicates that these neuropeptides have longer-lasting effects than such well-known neurotransmitters as NA or acetylcholine.
